Drag and drop your GIFs whenever you need or get a direct sharing link to any of your creations without switching from what you’re doing. Access recordings instantly: Grab any of your recent recordings right from the app in your Mac’s menu bar.In addition, new sharing options are added all the time. Currently, this handy GIF recorder is compatible with Dropbox, Google Drive, and Imgur, all of which can be accessed without any special logins or accounts. Share results over the cloud: Take your creations online to make them accessible from any device with an internet connection.In the end, you can even pick the part of the loop you like best. Gifox offers a complete variety of options, whether it’s to record screens or their desirable elements, as well as choosing FPS. Record GIFs the way you like: Decide what exactly you wish to record and the preferable way to do this.Simply proceed to the Settings > Compression tab to get it right. With Gifox you decide on the output quality and file size your animations should feature. And don’t forget to take advantage of the advanced compression options. Customize the Gif compression: Use this screen capture GIF application to grab a screencast as a GIF at any time.To start recording, simply go for the corresponding Window selection mode or use the Command + Shift + 6 keyboard shortcut. Frame a single-window: Easily and quickly record just one perfect app window with no overlaps or cuts instead of taking multiple screenshots to help your team reveal that naughty bug.Once you are done, just hit the Stop button and Gifox will automatically create a lightweight GIF, saving it to your Downloads folder. Or use the Cmd + Shift + 5 keyboard shortcut to instantly record your onscreen activity. Select any screen area: Create a GIF out of the particular area of your screen by selecting it and simply hitting Record.Molecular remissions were documented in two patients with mantle cell NHL.īased on the results of this pilot study, we conclude that the R-GIFOX regimen is feasible, tolerable, effective and able to mobilize peripheral stem cells in patients with relapsed and refractory aggressive NHL. Failure-free survival was 79.6% at median follow-up of 6 months (range 2-12). Hematologic and extra-hematologic toxicity was tolerable. Effective CD34(+) cell mobilization was obtained in four of six eligible patients and two had ASCT. The overall response rate assessed after three courses of R-GIFOX was 77%, with seven complete responses and three partial responses. Thirteen patients completed at least three courses of therapy and were evaluable for response. The median number of R-GIFOX courses delivered was 4 (range 1-6). Patients had received a median of two previous treatment lines (range 1-4). Responses were evaluated by the integrated FDG-PET/IWC criteria after the third course and at the end of the entire program.įourteen patients (median age 63 years, range 37-78 years) with relapsed (n = 9) or primary progressive (n = 5) aggressive (diffuse large cell, mantle cell, follicular G3), advanced (stage IV 71%), poor risk (IPI 3-5 50%) NHL were accrued in this pilot study.
Treatment was given every 2 weeks with G-CSF support (5 microg/kg/day or 10 microg/kg/day at the end of the third course for stem cell mobilization). R-GIFOX consisted of rituximab (375 mg/m(2) on day 1), gemcitabine (1000 mg/m(2) on day 2), oxaliplatin (130 mg/m(2) on day 3) and ifosfamide (5 g/m(2) on day 3) as a 24-h single infusion in patients aged 65 years. Patients were scheduled to receive three courses of therapy followed by mobilization and ASCT or three more courses if ineligible for ASCT. We evaluated the clinical activity, toxicity and mobilizing capacity of a new salvage regimen, which combines gemcitabine and oxaliplatin with ifosfamide and rituximab (R-GIFOX) in patients with relapsed and refractory CD20(+) NHL. Since high-dose therapy (HDT) with autologous stem cell transplantation (ASCT) can cure a proportion of such patients, provided that a substantial tumor shrinkage is achieved, the development of more effective and less toxic salvage regimens remains a major challenge. The prognosis of patients with aggressive non-Hodgkin's lymphoma (NHL) relapsing or progressing after front-line therapy remains poor. Firefox has a setting dedicated to loading animated GIFs in its config utility and if it is disabled for any reason, GIFs will not load.
0 kommentar(er)
